Sign up to save your podcasts
Or
Share Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow
Did you know that using Bruton tyrosine kinase (BTK) inhibitors can lead to chemotherapy-free regimens for treating certain B-cell malignancies?
Credit available for this activity expires: 11/7/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983523?src=mkm_podcast_addon_983523
View all episodes
By Medscape Podcasts
4
77 ratings
Did you know that using Bruton tyrosine kinase (BTK) inhibitors can lead to chemotherapy-free regimens for treating certain B-cell malignancies?
Credit available for this activity expires: 11/7/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983523?src=mkm_podcast_addon_983523
More shows like Keeping Current
View all
Merriam-Webster's Word of the Day
1,251 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
497 Listeners
Neurology® Podcast
298 Listeners
Science Quickly
1,382 Listeners
HBR IdeaCast
163 Listeners
This Week in Cardiology
884 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
296 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
The Peter Attia Drive
8,498 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Medicine and the Machine
60 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
429 Listeners